Clinical Trials Browser

Phase 2 × HER2-negative Metastatic Breast Cancer × eribulin × Clear all

NCT06533722 2025-06-10

Adaptive Therapy for Post-Second-Line Advanced Breast Cancer

Phase 2 Completed

HER2-negative Metastatic Breast Cancer